Top Dallas, TX Biotech Companies (40)
Don't see your company?
Create a company profile
Almaden Genomics is accelerating genomic discovery with g.nome, a cloud-native platform designed to streamline genomic workflows. Brought to market by a team of bioinformaticians, engineers and industry professionals, Almaden’s g.nome platform allows for a low-code/no-code pipeline build. With a visual drag-and-drop pipeline builder that utilizes toolkits and pre-built workflows from a curated library, g.nome is giving power to researchers — enabling them to import custom code, handle big datasets reliably and optimize team collaboration from anywhere. With g.nome, research teams can do what they do best: focus on the science
Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species de-extinction, beginning with the woolly mammoth. Colossal is accepting humanity’s duty to restore Earth to a healthier state.
Trusted by the world's leading organizations, Point B is a consulting firm that works at the intersection of expertise, industry insight, and transformative technology. This collaborative approach enables you to solve your most important challenges, by bringing together the right mix of talent and technology to deliver greater value and impact. With over 850 associates in the US and 3000+ consultants around the world through our Nextcontinent partnership, we work where you do to deliver the change you seek.
Caris Life Sciences is a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine through quality and innovation. Where Molecular Science Meets Artificial Intelligence – Revolutionizing Cancer Care Understanding cancer at the molecular level can lead to better treatment options. Caris provides cancer patients and oncologists with reliable, high-quality, comprehensive molecular information to deliver on the promise of precision medicine.
Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 130 million patients annually. More information is available at www.stryker.com. Together with our customers, we are driven to make healthcare better.
Solis Mammography is a specialized healthcare provider that has been dedicated to helping women achieve and maintain breast health and peace of mind for more than 30 years and more than 5 million procedures. Headquartered in Addison, Texas, Solis operates 85 centers in nine major markets, including North Texas, Houston, Denver, Phoenix, Chicago, Philadelphia, Columbus, Nashville and Greensboro, and, through its affiliated brand Washington Radiology, Washington D.C., Maryland and Virginia. The company operates both wholly owned centers and multiple successful joint venture partnerships with large hospital systems and prominent medical institutions.
Creating fully human monoclonal antibodies that target and neutralize HIV and other infectious diseases.
Mentrik Biotech, LLC is a private biopharmaceutical company that was incorporated in December 2010 and is headquartered in Dallas, TX. The goal of Mentrik Biotech is to optimize oncology-based therapeutics to treat patients with significant unmet medical need.
Tenet Healthcare Corporation is one of the largest investor-owned health care delivery systems in the nation.
Dialectic Therapeutics is a biotechnology company which is created for innovative technologies to cure cancer.
Based on an R&D program started in 2005, Orano Med has developed new processes for producing high-purity lead-212 (Pb-212), a rare radioactive isotope. Lead-212 is currently at the heart of promising projects in nuclear medicine to develop new treatments against cancer. The innovative approach, known as targeted alpha therapy (TAT), recognizes and destroys cancer cells while limiting the impact on nearby healthy cells. Macrocyclics, Inc., an Orano Med company, is the global leader in high performance chelating agent technology, offering a broad range of services and products. For more information please visit www.macrocyclics.com.
Xcenda’s strategic consulting and field reimbursement services help pharmaceutical and biotech manufacturers thrive in global, value-driven healthcare markets. Our areas of expertise include health economics and outcomes research, reimbursement and global market access strategy, market research, and health policy analysis, as well as the development of value demonstration tools, scientific publications, training programs and outsourced field reimbursement teams. We apply a broad, yet strategically connected array of consulting services to help manufacturers identify, demonstrate, and deliver their brand’s value proposition to key healthcare stakeholders.
DJO Global provides intelligent medical devices and services. DJO® is a global provider of high-quality orthopedic devices, and is a top provider in the United States among the largest such companies globally, as measured by revenues. What sets DJO apart is a focus on the continuum of care. This includes specializations across all three phases of care: performance and mobility, surgical intervention and post-operative rehabilitation. Our products are marketed under a portfolio of brands including Aircast®, Chattanooga®, CMF™, Compex®, DJO Surgical®, DonJoy®, Dr. Comfort®, Exo®, MotionMD® and ProCare®.
Our mission is to increase conservation and conservation awareness by developing microclimate-controlled devices for plants. Through our work, we increase the total amount of livable space available to plants and animals.
We are a late-stage biopharmaceutical company focused on the development and commercialization of novel personalized therapeutics to treat cancer.
Vaxxinity is a U.S.-based global biotechnology company pioneering a new class of medicines to democratize health. Headquartered in Dallas, TX, with operations in the United States, Latin America, Europe and Asia, the company’s proprietary technology platform has enabled the innovation of synthetic peptide vaccines designed to prevent or treat infectious diseases, including COVID-19, and chronic diseases, including Alzheimer's, Parkinson’s, migraine, and hypercholesterolemia.. Vaxxinity has optimized its pipeline to achieve a potentially historic, global impact on human health. The key to the platform is the proprietary library of UBITh peptides, which are immunosilent, avoiding inflammation, and when linked to custom-designed target antigens, can elicit highly specific antibodies.
Precision Biologics is a Biotechnology company located in 5910 N Central Expy, Dallas, Texas, United States.
Re-gen Active Lab is an Irving, Texas, based Biotechnology Company established in 2018 with a goal of revolutionizing regenerative medicine through the development of novel stem cell therapy for wound healing, regeneration, anti-inflammatory, and well-being applications. We collaborate with hospitals and universities around the globe to exploit the paramount potential of stem cells through research and development. All our products are developed in our own cutting edge ISO Class 3 laboratory facility by highly trained scientists and engineers. We have total control over all the steps involved in our product development process to achieve high levels of safety, purity, potency, viability, and reproducibility (batch to batch consistency).
Inform Diagnostics, previously known as Miraca Life Sciences serves more than 5,500 patients each day, providing expert pathology services in the fields of dermatopathology, breast pathology, GI pathology, hematology/oncology pathology, and urologic pathology. Additionally, Miraca provides health IT consulting services, and has helped hundreds of practices with programs such as MIPS, quality reporting, Meaningful Use, security risk assessments, and HIPAA compliance. The company, previously known as Caris Diagnostics, was renamed Miraca Life Sciences in February 2012. In November 2017, Miraca Life Sciences was acquired by Avista Capital Partners. As a leader in anatomic pathology, Inform Diagnostics combines the rigor of an academic medical institution with the innovative spirit of a technology company. By working for Inform Diagnostics, you will have the opportunity to contribute alongside top multidisciplinary talented professionals, who are dedicated to meeting the needs of our clinician clients and their patients. You will work in a state-of-the-art environment with cutting-edge tools, breakthrough technologies and with world-renowned thought leaders. The company utilizes a forward-thinking business model seeking to make a profound difference in the quality of care for patients.
Work Your Passion. Live Your Purpose.
